论文部分内容阅读
目的分析探究微创颅内血肿清除术治疗高血压脑出血的临床疗效。方法将我院40例高血压脑出血患者病历资料进行回顾性分析,其手术时间为2015年1月至2015年12月,依据上述患者的手术方式将其进行分组,其中包括传统开颅手术(对照组)与微创颅内血肿清除术(研究组),将上述两组患者的神经功能缺损评分、巴氏指数及术后并发症发生率进行对比。结果研究组患者的神经功能缺损评分及BI评分均优于对照组,同时研究组患者的术后并发症发生率明显低于对照组,P<0.05。结论为高血压脑出血患者采用微创颅内血肿清除术进行治疗的临床疗效显著。
Objective To analyze the clinical efficacy of minimally invasive intracranial hematoma in the treatment of hypertensive intracerebral hemorrhage. Methods The data of 40 cases of hypertensive intracerebral hemorrhage in our hospital were analyzed retrospectively. The operation time was from January 2015 to December 2015, and the patients were divided according to the operation mode of the above patients, including traditional craniotomy Control group) and minimally invasive intracranial hematoma (study group). The neurological deficit score, Papanicum index and postoperative complication rate were compared between the two groups. Results The neurological deficit score and BI score in the study group were better than those in the control group. The incidence of postoperative complications in the study group was significantly lower than that in the control group (P <0.05). Conclusion The clinical efficacy of minimally invasive intracranial hematoma removal in patients with hypertensive cerebral hemorrhage was significant.